Ping An Insurance (Group) Company of China, Ltd., established in 1988 in Shenzhen, is a leading personal integrated financial services provider in China. As the first insurance company in the country to adopt a shareholding structure, Ping An has evolved to encompass three core businesses: insurance, banking, and investment. The company aims to foster the parallel growth of its traditional and non-traditional financial ventures. In its traditional business, Ping An focuses on creating a financial supermarket and enhancing customer migration. Concurrently, it seeks to innovate within non-traditional sectors by seamlessly integrating financial services into everyday life, covering areas such as health, housing, and entertainment. The Group strives to establish an integrated financial services platform that offers a comprehensive customer experience, promotes sustainable profit growth, and ensures long-term stability for its shareholders.
No.1333, Lujiazui Ring Road, Pudong New District, Shanghai, 200120, China
Dong Liu
Principal Partner
Mingzhe Ma
Chairman and CEO
Hui Zhou
Partner
128 past transactions
Hangzhou Yingde Gas
Corporate Round in 2024
Hangzhou Yingde Gas is a company that specializes in the manufacturing and sales of industrial automatic control system devices and electrical signal equipment.
Soterea
Series B in 2022
Soterea is a software company based in Tianjin, China, founded in 2014. The company specializes in the development of intelligent driving technology for commercial vehicles, aiming to enhance driving safety. Soterea's innovations include a high-precision sensing system, automatic braking features, and a cloud platform designed to assist drivers in avoiding incidents on the road.
Rain Med
Series D in 2021
Rain Med is a vascular interventional surgical robot developer focused on the development of coronary angiography systems.
Xgene Pharmaceutical
Series C in 2021
Xgene Pharmaceutical Inc. is a late-clinical stage pharmaceutical company established in 2015, based in the Cayman Islands. It focuses on developing small-molecule drugs aimed at treating chronic pain, infectious diseases, and tumors. Utilizing proprietary linker technology, Xgene creates novel, multimodal conjugated molecules that enhance the efficacy and tolerability of pain medications. The company's current programs are dedicated to addressing unmet needs in neurological disorders, making significant strides in the development of innovative treatments for these conditions.
Biren Technology
Series B in 2021
Biren Technology is a high-tech startup specializing in the design and development of intelligent processors for GPU and DSA computation architectures. The company offers a range of integrated software and hardware solutions aimed at enhancing intelligent computing capabilities, with applications in cloud computing, artificial intelligence training, graphics rendering, and high-performance general-purpose computing. Their hardware department focuses on creating versatile and specific computing solutions, while the software division is led by experienced professionals and engineers. Additionally, their research institute is dedicated to advancing new intelligent computing system technologies, particularly in innovative architectures and advanced compilation techniques. Through these efforts, Biren Technology aims to enable customers to utilize domestic chip solutions and achieve significant technological advancements across various high-tech sectors.
Apollomics
Series C in 2020
Apollomics, Inc. is a clinical-stage biopharmaceutical company based in Foster City, California, specializing in the development of innovative oncology therapies. Founded in 2016, the company focuses on creating both mono- and combination therapies that leverage the immune system while targeting specific molecular pathways involved in cancer proliferation. Apollomics' pipeline includes several promising assets such as CBT-101, an oral agent that disrupts the epithelial to mesenchymal transition pathway; CBT-102, which inhibits the MAP Kinase pathway along with angiogenesis; and two novel humanized monoclonal antibodies, CBT-501 and CBT-502, targeting the PD-1 and PDL-1 receptors, respectively. The company is also developing vebreltinib, a selective c-Met inhibitor for non-small cell lung cancer, and uproleselan, an E-Selectin antagonist intended for use alongside standard chemotherapy in acute myeloid leukemia. Apollomics aims to harness these innovative approaches to enhance cancer treatment outcomes.
Lepu Bio
Series B in 2020
Lepu Bio they have developed an oncology-focused pipeline of drug candidates, including ADCs, oncolytic virus drugs, and immunotherapies at clinical and pre-clinical stages.
DentaLink China
Series C in 2020
Developer of dental imaging technology and dental clinic management software. The company's software helps dental professionals accurately diagnose patient conditions through oral CT scanning, as well as keep track of patient records and appointments, enabling dental professionals to provide treatment more efficiently.
Wind
Funding Round in 2019
Wind Information is recognized as the leading firm in financial data, information services and solutions in China. We are dedicated to providing accurate and real-time data, as well as sophisticated information platforms for financial professionals.
Lixiangjia
Series D in 2019
The professional global Chinese overseas asset reconfiguration consulting service platform is dedicated to providing one-stop overseas asset product information support services for Chinese wealth management practitioners. It has set up branches in many cities across the country to provide institutions, financial planners and medium and high net worth families. Professional overseas asset reconfiguration plan.
Shijiazhuang Junlebao Dairy
Funding Round in 2019
Shijiazhuang Junlebao Dairy is a prominent dairy products company based in China, specializing in a diverse array of offerings that include fluid milks, flavored milk, yogurt, baby formula, and milk powder. The company has developed a comprehensive operational framework that encompasses the entire dairy industry chain, ensuring coordinated development and a focus on nutrition, health, and safety for its consumers. By prioritizing quality and innovation, Junlebao Dairy aims to meet the growing demand for dairy products in the market while promoting the well-being of its customers.
iTutorGroup
Acquisition in 2019
iTutorGroup is an online education provider founded in 1998, headquartered in Taipei City, Taiwan, with additional offices in Shanghai, China, and Santa Clara, California. The company offers a range of platforms designed for both students and business professionals, including VIPABC, TutorABC, VIPABCJr, and TutorABCJr for English language learning, as well as TutorMing for Mandarin Chinese language instruction. Additionally, iTutorGroup provides LiveH2H, a service for live translations in multiple languages. The company focuses on delivering individualized and personalized learning experiences, allowing instructors to tailor content to meet the specific needs of learners.
Lenovo Healthcare Information Technology (Lenovo HIT)
Corporate Round in 2019
Lenovo Healthcare is a cloud-based smart medical solution company for medical institutions.
Global Data Solutions
Post in 2019
Global Data Solutions designs, builds, and operates data centers in the People's Republic of China together with its subsidiaries. It provides colocation, managed hosting, and managed cloud services, as well as consulting services. Global Data Solutions's data centers service customers that primarily operate in the Internet and banking industries in Shanghai and Beijing municipalities; and Jiangsu, Guangdong, Sichuan, and Hebei Provinces. It serves cloud service providers, Internet companies, financial institutions, telecommunications and IT service providers, and large domestic private sector and multinational corporations. William Wei Huang founded Global Data Solutions in 2000. It has its headquarters in Shanghai in the People's Republic of China.
Zhangshang Tangyi
Series C in 2019
Zhangshang Tangyi is a health management platform with a focus on diabetes. It allows patients to upload their own health data to their mobile app and receive treatment guidance from doctors. Zhangshang Tangyi was founded in 2014 and is based in Hangzhou, Zhejiang.
Xiaoqule
Series A in 2018
Xiaoqule (Happy Community) is a Chinese community-focused e-commerce platform. It is a subsidiary of Gejia. Xiaoqule helps local businesses provide cost-effective products and services to the local community. On the platform, the consumer can order food such as seasonal fruits and vegetables from local businesses. Xiaoqule connects local businesses with local consumers, which shortens transportation time and maintains quality of goods. Xiaoqule also serves as a logistical company, providing transportation, technology, marketing and customer support.
Global Scanner
Series A in 2018
Global Scanner is a social e-commerce platform targeting the middle-class in China.
NextCure
Series B in 2018
NextCure, Inc. is a clinical-stage biopharmaceutical company based in Beltsville, Maryland, that specializes in the discovery and development of novel immunomedicines aimed at treating cancer and other immune-related diseases. The company focuses on restoring normal immune function through its lead product candidate, NC318, currently in Phase 2 clinical trials for advanced or metastatic solid tumors. In addition, NextCure is developing NC410, an immunomedicine designed to inhibit immune suppression mediated by Leukocyte-Associated Immunoglobulin-like Receptor 1. The company's research also includes preclinical programs targeting various immunomodulatory proteins associated with tumors and inflamed tissues. NextCure has established collaborations, including a licensing agreement with Yale University and a research partnership with Eli Lilly and Company, to further its innovative therapeutic approaches. Founded in 2015, NextCure is dedicated to advancing first-in-class immunotherapy solutions.
Xgene Pharmaceutical
Series B in 2018
Xgene Pharmaceutical Inc. is a late-clinical stage pharmaceutical company established in 2015, based in the Cayman Islands. It focuses on developing small-molecule drugs aimed at treating chronic pain, infectious diseases, and tumors. Utilizing proprietary linker technology, Xgene creates novel, multimodal conjugated molecules that enhance the efficacy and tolerability of pain medications. The company's current programs are dedicated to addressing unmet needs in neurological disorders, making significant strides in the development of innovative treatments for these conditions.
Lenovo Healthcare Information Technology (Lenovo HIT)
Series A in 2018
Lenovo Healthcare is a cloud-based smart medical solution company for medical institutions.
Jinjiang Environment
Post in 2018
Jin Jiang Environmental Holdings Limited is China's leading waste to energy operators.The company has successfully embarked on a road of environmentally-friendly energy industrialization that combines production, learning
Grab Financial Group
Venture Round in 2018
Grab Financial Group provides financial services across payments, rewards, lending, and insurance. A seamless point-of-sale (POS) system for merchants and a trusted mobile wallet of choice in Southeast Asia for payments such as in-store purchases, Grab transactions, and fund transfers.
Grab
Series H in 2018
Grab Holdings Inc. is a prominent online-to-offline service provider based in Singapore, focusing on mobile technology solutions for transportation across Southeast Asia. Founded in 2012 by Anthony Tan and Tan Hooi Lng, Grab integrates various transportation services through its platform, which includes offerings such as GrabTaxi, GrabCar, GrabHitch, GrabShare, GrabCoach, GrabShuttle, GrabShuttle Plus, GrabFamily, JustGrab, GrabNow, and GrabRental. The company operates in multiple countries, including Singapore, Indonesia, the Philippines, Malaysia, Thailand, Vietnam, and Myanmar. In addition to its headquarters in Singapore, Grab has offices in Seattle, Beijing, Bangalore, Jakarta, and Vietnam, further extending its reach and capabilities within the region.
Chemclin
Private Equity Round in 2018
Chemclin Biotech is a Chinese technical service provider specializing in in-vitro diagnostic instruments and auxiliary reagents for clinical diagnosis. The company develops, produces, and sells clinical immunochemiluminescence diagnostic testing reagents and instruments. Its services encompass a range of clinical inspection instruments, including chemiluminescence and biochemical reagents, as well as technical support, management, and certification. Additionally, Chemclin operates independent medical laboratories and is focused on introducing innovative diagnostic products and services to the Chinese market.
HashFish
Angel Round in 2018
HashFish provides bitcoin mining software and services.
JollyChic
Series C in 2018
JollyChic is an e-commerce platform founded in 2012 by Aaron Li, headquartered in China. It specializes in the online retail of a diverse range of consumer products, including clothing, shoes, bags, babywear, home goods, electronics, and various accessories. The platform aims to provide quality and stylish products at competitive prices, catering to a broad customer base. JollyChic's offerings also extend to items such as toys, bedding, wedding supplies, and cleaning tools, making it a comprehensive destination for online shoppers seeking a variety of products.
Tmunity
Series A in 2018
Tmunity Therapeutics, Inc. is a biotherapeutics company based in Philadelphia, Pennsylvania, focused on developing innovative immunotherapies for cancer, infectious diseases, and autoimmune conditions. Founded in 2015, Tmunity specializes in creating engineered T cells, including T Cell Receptor (TCR) engineered T cells and regulatory T cells (Treg), utilizing proprietary technologies to activate, expand, and genetically modify T cells sourced from peripheral blood, cord blood, and tumors. The company aims to harness the potential of T cells to provide personalized next-generation treatments and is advancing its clinical programs in various disease areas. Tmunity's team is comprised of experts in T-cell biology, regulatory affairs, and clinical development, with a strong track record in executing successful cell and gene therapy trials. Additionally, Tmunity has established a robust manufacturing platform that supports multi-center clinical studies across diverse therapeutic indications.
Hua Medicine
Series D in 2018
Hua Medicine is a clinical-stage drug development company based in Pudong, China, specializing in innovative therapies for diabetes and central nervous system (CNS) disorders. Founded in 2009 by experienced professionals in the pharmaceutical industry, the company is advancing its lead product, Dorzagliatin, an oral medication for Type 2 diabetes, which has reached the NDA enabling stage and is currently undergoing two Phase 3 trials in drug-naive and metformin-treated patients in China. Additionally, Hua Medicine is exploring mGLUR5, a novel drug candidate aimed at treating levodopa-induced dyskinesia in Parkinson's disease. The company has secured funding from prominent international venture capital firms and has in-licensed global rights to its diabetes drug, positioning itself as a key player in the treatment landscape for these chronic conditions.
Rani Therapeutics
Venture Round in 2018
Rani Therapeutics, LLC is a clinical-stage biotherapeutics company that focuses on the development of oral delivery technologies for large drug molecules, such as peptides, proteins, and antibodies. The company has created the RaniPill capsule, a proprietary and patented platform designed to administer biologics orally, offering a convenient alternative to traditional subcutaneous or intravenous injections. This capsule is engineered to deliver precise therapeutic doses upon reaching the small intestine. Rani Therapeutics is advancing various treatments, including TNFa inhibitors for inflammatory disorders, parathyroid hormone for osteoporosis, and human growth hormone for growth deficiencies. Additionally, their portfolio includes therapies for multiple sclerosis, type II diabetes, and various inflammatory diseases. Founded in 2012 and based in San Jose, California, Rani Therapeutics has conducted several preclinical and clinical studies to assess the safety and effectiveness of its technologies, building a robust intellectual property portfolio in the process.
TytoCare
Series C in 2018
TytoCare Ltd. is a healthcare technology company based in Netanya, Israel, with an additional office in New York, New York. Founded in 2011, TytoCare develops handheld devices and applications that facilitate on-demand medical examinations and diagnoses through virtual consultations with healthcare providers. Its product offerings include TytoHome for consumers, TytoPro for healthcare professionals, and TytoClinic for remote care locations. These solutions enable users to perform self-examinations of various body systems, including the heart, lungs, skin, and throat, while providing remote access to physicians for evaluation and treatment of common conditions such as ear infections, flu, and respiratory issues. The platform incorporates a cloud-based data repository, analytics, and machine learning algorithms, enhancing the accuracy and user experience of remote healthcare services. TytoCare has established a strategic partnership with Novant Health to further expand its reach in the telehealth market.
Tmunity
Series A in 2018
Tmunity Therapeutics, Inc. is a biotherapeutics company based in Philadelphia, Pennsylvania, focused on developing innovative immunotherapies for cancer, infectious diseases, and autoimmune conditions. Founded in 2015, Tmunity specializes in creating engineered T cells, including T Cell Receptor (TCR) engineered T cells and regulatory T cells (Treg), utilizing proprietary technologies to activate, expand, and genetically modify T cells sourced from peripheral blood, cord blood, and tumors. The company aims to harness the potential of T cells to provide personalized next-generation treatments and is advancing its clinical programs in various disease areas. Tmunity's team is comprised of experts in T-cell biology, regulatory affairs, and clinical development, with a strong track record in executing successful cell and gene therapy trials. Additionally, Tmunity has established a robust manufacturing platform that supports multi-center clinical studies across diverse therapeutic indications.
Kbp Biosciences
Series A in 2018
KBP Biosciences is a biotechnology research and development organization focused on creating innovative therapies for unmet medical needs, particularly in the fields of cardiovascular, respiratory, inflammatory, and autoimmune diseases. The company specializes in the research, development, and commercialization of new medicines, leveraging its expertise in medicinal chemistry and clinical development. By addressing gaps in treatment options, KBP aims to provide healthcare providers with effective solutions for managing conditions that currently lack adequate therapies.
StartUp Health
Venture Round in 2018
StartUp Health is investing in a global army of Health Transformers to achieve health moonshots. StartUp Health is on a 30-year mission to collaborate with entrepreneurs to improve the health and wellbeing of everyone in the world. Since 2011, StartUp Health has been investing in a global army of entrepreneurs -- called Health Transformers -- to achieve health moonshots: Access to Care, Cost to Zero, Cure Disease, End to Cancer, Women’s Health, Children’s Health, Nutrition and Fitness, Brain Health, Mental Health and Happiness, Addiction, Longevity, and Pandemic Response. StartUp Health has the world’s largest health innovation portfolio with more than 330 companies across six continents and 26 countries and is backed by leading investors including Advocate Aurora Health, Chiesi, Steve Case, Mark Cuban, Esther Dyson, Brad Feld, GuideWell, Jason Finger, Jerry Levin, Kaiser Permanente, Masimo, Novartis, Otsuka, and Ping An.
Rogrand
Series C in 2017
Beijing Rogrand E-Commerce Co., Ltd. is a leading pharmaceutical entire integration of industry chain service platform in China leading the innovation of new pharmaceutical business model. Since its inception in 2012, the company has always been driven by the goal of forging a circulation platform for the whole industry consisting of pharmaceutical industry, pharmaceutical business, pharmacy, clinic and medical institution.
Chexiang
Series B in 2017
Chexiang.com is a Chinese online-to-offline automotive trading platform under Shanghai-based auto maker SAIC Motor Co Ltd.
Fullerton Healthcare Corporation
Venture Round in 2017
Fullerton Health is a leading provider of corporate healthcare solutions across Asia Pacific with more than 225 fully-owned medical centres, a network of more than 8,000 medical providers, 2,000 employees including more than 1,200 healthcare professionals, and six call centres across five countries.
Tikin Media
Angel Round in 2017
Tikin Media is an innovative advertising company that specializes in elevator marketing solutions, connecting property owners with advertisers. The company installs advanced commercial projectors in elevators, creating a unique advertising platform that enhances consumer exposure to brands. Tikin Media has attracted significant investment from major players in the industry, including Baidu Venture Capital, Sequoia China, and IDG. With a focus on high-end commercial building media operations, Tikin Media has developed proprietary elevator projection technology that transforms traditional advertising methods, enabling mobile interconnectivity and incorporating programmatic ordering and big data analysis capabilities.
Annoroad
Series C in 2017
Annoroad Gene Technology, established in 2012 and headquartered in Beijing, is a prominent player in China's genomics sector, known primarily for its Non-Invasive Prenatal Testing (NIPT) services and advanced genomic research capabilities. The company specializes in next-generation sequencing (NGS) technologies applied to human health and life science research. Annoroad has received multiple accolades, including recognition as a national high-tech enterprise and a pilot organization for high-throughput sequencing clinical applications. It boasts a comprehensive product portfolio that includes the NextSeq 550AR sequencer and various genomic testing reagents, supporting diagnostic applications in human reproduction, oncology, and rare diseases. Additionally, Annoroad has developed SolarGenomics, a cloud-based platform for genomic big data services, and has established robust research and development capabilities, reinforced by a skilled workforce. The company's extensive service offerings span the entire genomics industry chain, enhancing its reputation and fostering partnerships within the sector.
Prenetics
Series B in 2017
Prenetics Limited is a DNA biotechnology company based in Central, Hong Kong, specializing in pharmacogenomics and health sciences. The company offers the iGenes PGx test, which assists physicians in determining the appropriate medication and dosage for patients based on their genetic profiles while identifying potential adverse drug effects. In addition to pharmacogenomics, Prenetics provides ONEdna, a DNA screening service that delivers insights and actionable recommendations based on an individual’s genetic makeup. Its consumer health initiative is represented by the IM8 brand, while the clinical division includes Insighta, which focuses on multi-cancer early detection technologies, and ACT Genomics, known for its FDA-approved genomic profiling of solid tumors. Prenetics has formed strategic partnerships with notable organizations, including The Lippo Group and New Horizon Health Limited. The company was established in 2007 and underwent a name change from Multigene Diagnostics Limited to Prenetics Limited in November 2014.
Che Youyuan
Series A in 2017
Che Youyuan provides assistance services to the majority of car owners at any time, any place, and any vehicle. Rescue service products and peripheral products include towing service, telephone service, tire replacement service, field repair, dianbao, multi tool pen, and rescue t-shirt
Huya.com
Series A in 2017
Huya.com is China's interactive broadcast platform, enriched by the world's first communications service operators. The company's live products cover PC, Web, and mobile three-end, and have nearly 300 featured channels in 4 categories including online games, single-game hot games, mobile games, and entertainment variety, covering e-sports, music, sports, beauty, outdoor, A wide range of popular content such as reality shows, variety shows, entertainment, and food.
Aiqi Technology
Series A in 2017
Beijing AIQI Technology Co., Ltd. is an Internet technology company focused on the research and development of artificial intelligence and robotic technology. The company has assembled a team of enthusiastic and innovative individuals dedicated to exploring advancements in intelligent equipment, resulting in the acquisition of numerous patents over the past three years. A notable achievement includes a partnership with a prominent technology firm, positioning AIQI as the sole provider of DIY intelligent robots within that company's ecosystem. AIQI specializes in creating interactive DIY family robots designed for K-12 STEM education, leveraging advanced AI technology to enhance human-machine interaction. Their products are user-friendly, updatable, and aim to inspire creativity while providing engaging experiences for users in modern life.
Global Switch Holdings
Secondary Market in 2016
Global Switch is a leading operator of large-scale, carrier-neutral data centers, owning and managing approximately 3,000,000 square feet of space across Europe and the Asia-Pacific region. Established in 1998, the company has built a strong reputation for delivering reliable and efficient data center solutions tailored to the needs of a diverse clientele, including government agencies, financial institutions, enterprises, and global systems integrators. Global Switch emphasizes strategically located facilities that offer high resilience and low latency, positioning its data centers near key urban centers and internet hubs to optimize connectivity and service delivery for its customers.
TapTap
Series A in 2016
TapTap is an online platform dedicated to gaming enthusiasts, serving as both a community hub and a marketplace for game downloads and purchases. It facilitates interaction among users while providing access to a diverse range of games, catering to various interests and preferences within the gaming community. By combining social features with a robust selection of games, TapTap aims to enhance the gaming experience and foster connections among players.
Innovent Biologics
Series D in 2016
Innovent Biologics, Inc. is a leading biopharmaceutical company based in Suzhou, China, specializing in the discovery, development, manufacture, and commercialization of monoclonal antibodies. The company focuses on various therapeutic areas, including oncology, ophthalmology, immunology, and metabolic diseases. Its flagship product, Tyvyt (sintilimab), is an anti-PD-1 monoclonal antibody used in the treatment of several cancers, including Hodgkin’s lymphoma and esophageal carcinoma. Innovent is also developing a range of additional drug candidates, such as biosimilars for rituximab and adalimumab, as well as novel monoclonal antibodies targeting conditions like hypercholesterolemia and different types of cancer. With a robust pipeline and over 30 strategic collaborations with global pharmaceutical companies, Innovent is well-positioned in the biopharmaceutical landscape. The company's founders and management team bring extensive experience in biologics, having participated in the launch of notable products across international markets. Innovent was founded in 2011 and has established itself as a prominent player in the biotechnology sector in China.
Gegejia.com
Series A in 2016
Gege home, under the Zhejiang Grid Network Technology Co., Ltd., focused on imported food sales, on-line time March 26, 2015, on-line orders within 30 days more than 10,000 single orders for millions of dollars. Gege home core team all have 5 years to 10 years of e-commerce-related experience, and a strong accumulation of industry resources.
Fe3 Medical
Series B in 2016
Fe3 Medical, Inc., operating as Bria Medical, specializes in developing transdermal therapies aimed at treating iron deficiency anemia. The company has created a disposable transdermal patch that delivers around 10 milligrams of iron directly through the skin, effectively bypassing the gastrointestinal tract and minimizing side effects commonly associated with oral iron supplements. Primarily targeting women, Fe3 Medical focuses on providing a safe and non-toxic solution for individuals suffering from this condition. Established in 2008, the company is headquartered in San Antonio, Texas.
Nanopep
Seed Round in 2016
Nanopep is a nano-biomedical company focused on advancing cancer prevention and precision medicine through innovative technologies. The company develops platform technologies that facilitate personalized medicine, including SPRI and MALDI-TOF MS microarrays for high-throughput peptide screening. Additionally, Nanopep specializes in the enrichment of circulating tumor cells using nano-beads, which underpins its protein-based liquid biopsy assay. The company targets three primary user groups: it provides preventative detection services for healthy individuals, assesses and identifies risks for patients with tumors, and offers treatment solutions for those with PD-L1 expression. Through these efforts, Nanopep aims to improve early detection and treatment outcomes in oncology.
Wanjia
Angel Round in 2016
Wanjia provides dentistry, chinese medicine, pediatrics, and gynaecology services. They provide services for children and adults. Their customers' inquiries are addressed through phone, email, and online applications.
Zhuanhua Yixue Wang
Series A in 2016
Zhuanhua Yixue Wang is a translational medicine portal for gene testing, cell therapy, in vitro diagnosis, precision medicine, and other core segments of translational medicine that provide original content and in-depth industry analysis. They provide news reports for doctors, researchers, enterprises, and related practitioners with the goal of leading the development of the industry. They offer services for forums, salons, and training courses.
Fabric Genomics (formerly Omicia)
Series B in 2016
Fabric Genomics is making genomics-driven precision medicine a reality. We provide clinical decision support software that enables clinical labs, hospital systems and country-sequencing programs to gain actionable genomic insights, resulting in faster and more accurate diagnoses and reduced turnaround time. Fabric’s end-to-end genomic analysis platform incorporates proven AI algorithms, and has applications in both hereditary disease and oncology. Headquartered in Oakland, California, Fabric Genomics was founded by industry veterans and innovators with a deep understanding of bioinformatics, large-scale genomics and clinical diagnostics.
Applied StemCell
Series D in 2016
Applied StemCell Inc. (ASC) is a fast growing biotechnology company providing animal and cell line models as tools for drug discovery and diagnostics. Using our proprietary TARGATT™ gene modification technology, we make site-specific Knockin mouse, rat and human cell line models fast and efficient for pharmaceutical and academic community. Based on our Proprietary Technologies, we focus on the development and commercialization of: Mouse models (Knockin, Knockout, Transgenic, Site-specific transgenic - TARGATT™, Humanized mouse models) Rat models Human cell line model (Gene modified iPSC - adult stem cell / progenitor cells - differentiated cells) Stem cell culture products (optimized stem cell medium and reporters) Gene engineering in stem cells or other mammalian cells (e.g. generation of protein - production mammalian cell lines) We are striving to improve and expand our technologies and product lines to meet the increasing requirements of biomedical community. ASC welcomes your comments, suggestions and ideas.
Rogrand
Series B in 2016
Beijing Rogrand E-Commerce Co., Ltd. is a leading pharmaceutical entire integration of industry chain service platform in China leading the innovation of new pharmaceutical business model. Since its inception in 2012, the company has always been driven by the goal of forging a circulation platform for the whole industry consisting of pharmaceutical industry, pharmaceutical business, pharmacy, clinic and medical institution.
Shenchu Jia Yan
Angel Round in 2016
Shenchu Jia Yan is an online restaurant reservation platform.
F-ROAD
Series E in 2016
Shanghai F-road Commercial Services Co., Ltd. specializes in mobile financial services tailored for financial institutions. Founded in 2008 and based in Shanghai, the company provides a variety of offerings, including encrypted mobile banking, daily online services, community bank development and operation, as well as asset management for regional banks. F-road also plays a crucial role in promoting inclusive finance by assisting the transformation and upgrading of regional banks and activating grassroots financial organizations. Utilizing advanced technologies such as big data, cloud platforms, and artificial intelligence, F-road delivers comprehensive solutions through two platforms—a local life platform and a smart credit platform—alongside eID operation services, enhancing the financial capabilities of regional banks.
AutoHome
Acquisition in 2016
Autohome Inc. is the premier online platform for automobile consumers in China, operating two key websites, autohome.com.cn and che168.com. Founded in 2008, Autohome provides a wide range of independent and interactive content aimed at assisting automobile buyers and owners. It is recognized as the leading automotive website in China, boasting the highest number of daily unique visitors and engagement metrics. The platform serves as an essential marketing channel for automakers and dealers, who utilize its advertising services for brand promotion, new model launches, and sales initiatives. Additionally, Autohome offers subscription services for dealers, enabling them to showcase their inventory and services online, thus expanding their reach to millions of potential customers. With a significant market share in online automotive advertising and lead generation, Autohome is a vital resource in the Chinese automotive market.
Meidaila1221
Series B in 2016
Meidaila is a computer software company offering technology solutions.
Prenetics
Series A in 2016
Prenetics Limited is a DNA biotechnology company based in Central, Hong Kong, specializing in pharmacogenomics and health sciences. The company offers the iGenes PGx test, which assists physicians in determining the appropriate medication and dosage for patients based on their genetic profiles while identifying potential adverse drug effects. In addition to pharmacogenomics, Prenetics provides ONEdna, a DNA screening service that delivers insights and actionable recommendations based on an individual’s genetic makeup. Its consumer health initiative is represented by the IM8 brand, while the clinical division includes Insighta, which focuses on multi-cancer early detection technologies, and ACT Genomics, known for its FDA-approved genomic profiling of solid tumors. Prenetics has formed strategic partnerships with notable organizations, including The Lippo Group and New Horizon Health Limited. The company was established in 2007 and underwent a name change from Multigene Diagnostics Limited to Prenetics Limited in November 2014.
Fe3 Medical
Series B in 2016
Fe3 Medical, Inc., operating as Bria Medical, specializes in developing transdermal therapies aimed at treating iron deficiency anemia. The company has created a disposable transdermal patch that delivers around 10 milligrams of iron directly through the skin, effectively bypassing the gastrointestinal tract and minimizing side effects commonly associated with oral iron supplements. Primarily targeting women, Fe3 Medical focuses on providing a safe and non-toxic solution for individuals suffering from this condition. Established in 2008, the company is headquartered in San Antonio, Texas.
JMDNA
Series B in 2016
JMDNA (Shanghai) Bio-Medical Technology Co., Ltd., established in 2011 and headquartered in Shanghai, China, specializes in molecular diagnostics with a focus on women and children. The company provides a range of research and application services, including non-invasive genetic testing and diagnostics for liver diseases and tumors. JMDNA aims to deliver comprehensive and precise genetic testing solutions that enable early diagnosis of hereditary conditions and diseases affecting mothers and children. By collaborating with medical institutions and industry partners, JMDNA is dedicated to advancing clinical applications and improving healthcare outcomes in its specialized field.
Yunda Express
Private Equity Round in 2016
Yunda's business is mainly express delivery business, but also includes warehousing business and supply chain business. As of December 31, 2019, Yunda's service network covers 31 provinces (regions, municipalities) and Hong Kong, Macao, and Taiwan regions across the country, reaching more than 30 countries and regions around the world, and providing high-quality lifestyle experiences for domestic and foreign customers. The company is one of the first batches of 44 private enterprise headquarters in Shanghai. It has been included in the BrandZ Top 100 Most Valuable Chinese Brands list twice, and successively won honors such as "2014-2015 National Civilized Unit in Transportation Industry". Yunda was included in the MSCI China Index and ranked among the top three in the "2018 China United 100" ranking.
Rani Therapeutics
Venture Round in 2016
Rani Therapeutics, LLC is a clinical-stage biotherapeutics company that focuses on the development of oral delivery technologies for large drug molecules, such as peptides, proteins, and antibodies. The company has created the RaniPill capsule, a proprietary and patented platform designed to administer biologics orally, offering a convenient alternative to traditional subcutaneous or intravenous injections. This capsule is engineered to deliver precise therapeutic doses upon reaching the small intestine. Rani Therapeutics is advancing various treatments, including TNFa inhibitors for inflammatory disorders, parathyroid hormone for osteoporosis, and human growth hormone for growth deficiencies. Additionally, their portfolio includes therapies for multiple sclerosis, type II diabetes, and various inflammatory diseases. Founded in 2012 and based in San Jose, California, Rani Therapeutics has conducted several preclinical and clinical studies to assess the safety and effectiveness of its technologies, building a robust intellectual property portfolio in the process.
Oscar Health
Private Equity Round in 2016
Oscar Health is a health insurance company that offers a range of plans for individuals, families, and small groups, as well as Medicare Advantage options for adults aged 65 and older. Founded in 2012 by Joshua Kushner, Kevin Nazemi, and Mario Schlosser, the company is headquartered in New York City. Oscar Health employs technology and data-driven solutions to enhance the healthcare experience, providing virtual care, doctor support, and appointment scheduling services. Its plans are available in select regions of New York, New Jersey, California, and Texas, catering to those who do not receive employer-sponsored health insurance.
YICHUAN
Angel Round in 2016
YICHUAN is a men's lifestyle media services company.
Bochewang
Series B in 2016
Bochewang is a professional B2B trading platform that specializes in motor cars and accessories, catering to auto repair shops, dismantle shops, used car dealers, and parts sellers. The platform comprises three main sections: an auction center for selling accident and used vehicles, a vehicle showroom for trading repaired used cars, and an accessories platform for exchanging various auto parts. Bochewang's online service facilitates second-hand car auctions and provides essential parts and financial services, allowing users to conduct transactions efficiently and effectively. To access the platform's features, users must complete registration, payment, and authentication.
20/20 Gene Systems
Series A in 2016
20/20 GeneSystems (‘20/20’) was founded in May of 2000 to develop and promote an innovative proteomics product line that provides drug companies, biodefense specialists and life scientists with new tools for protein analysis. Their headquarters are in the heart of the biotechnology corridor in Rockville, Maryland in close proximity to the National Institutes of Health with which they have extensive collaborations. 20/20 GeneSystems develops and commercializes innovative, proprietary diagnostics tests that aid in the fight against cancer. These tests generally fall into three categories: - Personalized Medicine: Their patented platform technology for measuring biomarkers in tumors is highly unique in that it combines the visual advantages of classical pathology with the multiplex capabilities needed as a result of genomics and proteomics. This technology is now being used to develop tests to predict responses to several new targeted therapies for kidney and lung cancer. - Early detection of lung cancer: 20/20 is developing a blood test for the early detection of lung cancer. This product will be used for screening smokers and former smokers to pre-select or enrich the patient population to receive annual CT scanning long before the disease becomes symptomatic. - Biological Detection: 20/20 is on the leading edge of developing technologies to help in the detection of biological toxins.
Zhangshang Tangyi
Series B in 2016
Zhangshang Tangyi is a health management platform with a focus on diabetes. It allows patients to upload their own health data to their mobile app and receive treatment guidance from doctors. Zhangshang Tangyi was founded in 2014 and is based in Hangzhou, Zhejiang.
Xieche.com
Series B in 2016
Xieche.com offers comprehensive automobile maintenance and repair services tailored for car owners. Their extensive range of services includes sheet metal painting, electromechanical repair, improving air conditioning efficiency, oil changes, and tire rim cleaning. Xieche emphasizes customer education by providing detailed information about each maintenance process, fostering transparency in car care. Additionally, the company offers convenient options for maintenance, enabling customers to choose between home service and in-store repairs, ensuring that car owners can easily access the services they need to keep their vehicles in optimal condition.
Kangzhi Pifuyisheng
Series A in 2015
Kangzhi Pifuyisheng is an online consultation service platform.
Alchemy Information
Angel Round in 2015
ALCHEMY INFORMATION is a provider of game art services tailored for the gaming industry, specializing in 3D art production, animation, and visual effects for various platforms, including PC, AAA consoles, and mobile devices. The company focuses on outsourcing game art to support game development companies, ensuring high-quality production that meets the needs of its clients. With a commitment to delivering self-developed entertainment products, ALCHEMY INFORMATION aims to enhance the gaming experience for a global audience.
Black & White Campus
Series A in 2015
Black & White Campus is a company that specializes in campus promotion activities and provides a mobile social application tailored for students. This application serves as a platform where students can engage in discussions and organize meet-ups on various topics, fostering a sense of community and connectivity within educational environments. By focusing on the unique needs of the student demographic, Black & White Campus aims to enhance social interaction and collaboration among peers.
MOGU
Series E in 2015
MOGU is an consumer platform aimed towards women, achieved through e-commerce, social media, influencers and content driven services. Their content covers all areas of the fashion world and they have a huge range of age groups and interest covered through their numerous apps and platform. MOGU Inc. is a destination of fashion. With various kinds of fashion content and abundant fashion products, MOGU Inc. allows people to discover and share fashion trends while fully enjoying high-quality shopping experience. In 2011, MOGU Inc. launched fashion platform under the Mogujie brand . In 2016, the merger of Mogujie and Meilishuo was completed.Currently, MOGU Inc.'s online platform includes Mogujie.com and Meilishuo.com websites, mogujie mobile app, Meilishuo mobile app, Uni mobile app and several WeChat Mini programs.
Anxin Doctor
Series A in 2015
Anxin Doctor operates a mobile healthcare platform focused on maternal and pediatric health. It connects patients with obstetricians, gynecologists, and pediatricians, facilitating access to specialized medical care. The platform allows users to receive healthcare advice and book clinical appointments through its application, thereby enhancing health outcomes for patients. By bridging the gap between healthcare professionals and patients, Anxin Doctor aims to streamline the process of accessing essential medical services in the fields of maternal and child health.
NCARS
Angel Round in 2015
NCARS provides chain services such as machine repair, body spraying, insurance, and accident vehicle. They offer brand marketing management, accessories supply chain, technician training, and service management.
Rakunew
Corporate Round in 2015
Rakunew is an e-commerce company that offers a range of gadgets and new products that are popular overseas. The company is an international mail-order company that sells innovative household items and gadgets that are well-liked abroad but hard to find in Japan.
Qukaidan
Series B in 2015
Enterprise service
58 Daojia
Series A in 2015
The company provides information on and access to high-quality offline services such as cleaning, moving, babysitting, beauty care, and many other categories in approximately 30 cities in China. With its location-based order processing system, 58 Home's platform directly connects customers to the nearest independent service providers. Founded in September 2014, 58 Home is a multi-category local services platform in China.
Zhangshang Tangyi
Series A in 2015
Zhangshang Tangyi is a health management platform with a focus on diabetes. It allows patients to upload their own health data to their mobile app and receive treatment guidance from doctors. Zhangshang Tangyi was founded in 2014 and is based in Hangzhou, Zhejiang.
Clinicloud
Seed Round in 2015
CliniCloud was founded by Dr. Hon Weng Chong and Dr. Andrew Lin, two physicians who have been friends since medical school. They realized that today’s patients are starting to play a more active role in their own care, and wanted to equip everyone with the right tools to make better healthcare decisions. CliniCloud started life as “StethoCloud, the Smart Stethoscope”, which won the 2012 Imagine Cup grant and was covered in Bloomberg, Wired, CNET, TechCrunch and others. The non-contact thermometer was added after we recognized that temperature was also a crucial data point for diagnostic decisions. After two years of hard work, we are proud to announce our first commercial product and will continue to innovate with our software and devices to bring the future of healthcare home.
Ativa Medical
Series B in 2015
Ativa Medical is a medical device manufacturing company that is working to make diagnostic test results available in moments, rather than hours and days. The company specializes in the fields of medical device development, point of care diagnostics, microfluidics, and hematology. The company was founded in 2008 and headquartered in Saint Paul, Minnesota.
Payoneer
Series E in 2015
Payoneer Inc. is a financial technology company that operates a cross-border payments platform, facilitating transactions for businesses and professionals across various countries and currencies. Founded in 2005 and headquartered in New York, Payoneer offers a range of services, including its Global Payment Service, which allows users to receive local bank transfers from the United States, European Union, and Japan directly into their Payoneer accounts. Additionally, the platform supports mass payouts, enabling Indian companies and marketplaces to transfer funds internationally. Payoneer primarily serves freelancers, e-commerce businesses, and the online advertising sector, and has formed strategic partnerships with various organizations to enhance its service offerings.
Beijing Express Channel Cold Chain Logistics Co.
Series A in 2015
Beijing Express Channel Cold Chain Logistics Co., Ltd., located in Beijing, China, specializes in providing logistics solutions focused on cold chain services. The company offers a range of services, including cold chain urban distribution, less-than-truckload transportation, and home delivery options. By delivering economical and suitable cold chain logistics solutions, the company aims to meet the diverse needs of its customers in ensuring the safe and efficient transport of temperature-sensitive goods.
Didi
Private Equity Round in 2015
Didi Chuxing is a mobile transportation platform that offers app-based transportation services. The company offers a mobile tech-based mobility option for users across, including taxi-hailing, private car-hailing, Hitch (social ride-sharing), DiDi Chauffeur, DiDi Bus, DiDi Test Drive, DiDi Car Rental, and DiDi Enterprise Solutions. As a practitioner in the sharing economy initiative, DiDi is committed to working with communities and partners to solve transportation, environmental challenges, and employment problems using big data-driven deep-learning algorithms that optimize resource allocation.
Secoo
Series E in 2015
Secoo is a luxury products and services platform based in China, facilitating global trade between buyers and suppliers through both online and offline channels. The company operates an online retail platform and experience centers in key cities such as Beijing, Shanghai, Chengdu, and others, as well as in Malaysia. Secoo collaborates with renowned brand boutiques, allowing customers to pick up products ordered online at physical locations. The majority of its revenue is derived from its online business, with a significant focus on the Chinese market. Established in 2011, Secoo has built a substantial membership base of 500,000, including over 20,000 VIP members. The company aims to enhance its presence by establishing exhibition centers in major cities, further solidifying its position in the luxury retail sector.
Bochewang
Series A in 2015
Bochewang is a professional B2B trading platform that specializes in motor cars and accessories, catering to auto repair shops, dismantle shops, used car dealers, and parts sellers. The platform comprises three main sections: an auction center for selling accident and used vehicles, a vehicle showroom for trading repaired used cars, and an accessories platform for exchanging various auto parts. Bochewang's online service facilitates second-hand car auctions and provides essential parts and financial services, allowing users to conduct transactions efficiently and effectively. To access the platform's features, users must complete registration, payment, and authentication.
Rogrand
Series A in 2015
Beijing Rogrand E-Commerce Co., Ltd. is a leading pharmaceutical entire integration of industry chain service platform in China leading the innovation of new pharmaceutical business model. Since its inception in 2012, the company has always been driven by the goal of forging a circulation platform for the whole industry consisting of pharmaceutical industry, pharmaceutical business, pharmacy, clinic and medical institution.
Purple Clinic
Series A in 2015
Purple Clinic operates a WeChat-based doctor-patient service platform tailored to meet the specific needs of medical partners. The platform facilitates communication between doctors and patients through an online medical mobile application, enhancing consultation services in various fields including dermatology, pediatrics, gynecology, andrology, and internal medicine. By integrating digital marketing project management with medical services, Purple Clinic aims to streamline the interaction between healthcare providers and patients, ultimately improving the quality of care and accessibility of medical advice.
Medbanks
Series A in 2015
Medbanks Network Technology, founded in 2014 and based in Beijing, specializes in data processing services for the healthcare sector. The company focuses on developing an oncology database that compiles clinical and professional medical service information gathered from hospitals. This resource aims to enhance the understanding and management of cancer care. In addition, Sipai Health Technology Co Ltd operates within the medical technology and health management space in China, encompassing three main segments: specialty pharmacy, physician research assistance, and health insurance services. The specialty pharmacy segment is the primary revenue driver, while the company predominantly conducts its business within the People's Republic of China.
eXiche
Series A in 2015
eXiche provide users with Internet booking to the shop car wash, door car wash services.
Rainbow Medical Innovation
Venture Round in 2015
Rainbow Medical Innovation is a private operational company established in 2007 and based in Herzliya, Israel. It focuses on seeding and developing companies that create innovative medical devices, primarily those invented by Yossi Gross. The company aims to address significant unmet needs in various medical fields, contributing to advancements in healthcare while fostering the growth of its portfolio companies. By concentrating on breakthrough technologies, Rainbow Medical Innovation seeks to deliver substantial returns for its investors.
WanJiangLong
Series A in 2015
Wanjianglong operates in the internet and commercial real estate sectors, providing comprehensive operational service solutions for commercial real estate projects. Their offerings encompass all stages of construction, opening, and ongoing operations, aimed at enhancing the performance of commercial complexes. By facilitating the attraction of new customers, promoting engagement, retaining existing clients, and boosting sales, Wanjianglong helps commercial properties thrive. Additionally, the company develops software focused on consumer data collection and analysis, which assists shopping center merchants in understanding customer preferences. This enables businesses to create targeted marketing strategies, ultimately expanding their customer base and improving sales outcomes.
Mogoroom
Series A in 2014
Mogoroom currently operates in Shanghai and Beijing, providing standardized rental apartments to young professionals seeking more convenient living environment services.
Qukaidan
Series B in 2014
Enterprise service
Qiaobu Jianli
Series A in 2014
Qiaobu Jianli provides online portal services for resume templates to students. They offer black and white resume templates and colour resume templates. Thye also offer industries related resume templates such as communication , biology, pharmaceutical, civil engineering.
eToro
Series D in 2014
eToro is a multi-asset investment platform founded in 2007 and based in London, United Kingdom. The platform enables users to trade a variety of financial instruments, including currencies, commodities, indices, crypto assets, and stocks. eToro promotes a social trading environment where over 23 million registered users can share investment strategies, allowing individuals to learn from successful investors by following their approaches. The platform offers features such as copy trading, which allows users to automatically replicate the trades of experienced traders, fostering a community focused on knowledge sharing and wealth growth. eToro aims to simplify and democratize access to global markets, making trading and investing more transparent for everyone.
Black & White Campus
Angel Round in 2014
Black & White Campus is a company that specializes in campus promotion activities and provides a mobile social application tailored for students. This application serves as a platform where students can engage in discussions and organize meet-ups on various topics, fostering a sense of community and connectivity within educational environments. By focusing on the unique needs of the student demographic, Black & White Campus aims to enhance social interaction and collaboration among peers.
Prime Cloud
Series A in 2014
Prime Cloud is a cloud service company that focuses on desktop cloud, education informatization and cloud platforms.
Goku remote control
Angel Round in 2014
Goku Remote Control is a developer of an innovative application that transforms smartphones into remote controls, integrating essential television features. The application allows users to access live television broadcasts and on-demand content while offering the ability to install various applications. With a focus on enhancing the viewing experience, Goku Remote Control provides a new interface that enables users to stream high-definition live broadcasts from multiple channels, making it a versatile tool for modern television consumption.
Payoneer
Series D in 2014
Payoneer Inc. is a financial technology company that operates a cross-border payments platform, facilitating transactions for businesses and professionals across various countries and currencies. Founded in 2005 and headquartered in New York, Payoneer offers a range of services, including its Global Payment Service, which allows users to receive local bank transfers from the United States, European Union, and Japan directly into their Payoneer accounts. Additionally, the platform supports mass payouts, enabling Indian companies and marketplaces to transfer funds internationally. Payoneer primarily serves freelancers, e-commerce businesses, and the online advertising sector, and has formed strategic partnerships with various organizations to enhance its service offerings.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.